Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that! / Ried-Larsen, Mathias; MacDonald, Christopher S.; Johansen, Mette Y.; Hansen, Katrine B.; Christensen, Robin; Almdal, Thomas P.; Pedersen, Bente K.; Karstoft, Kristian.
I: Diabetes - Metabolism: Research and Reviews (Print Edition), Bind 34, Nr. 5, e2999, 2018.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!
AU - Ried-Larsen, Mathias
AU - MacDonald, Christopher S.
AU - Johansen, Mette Y.
AU - Hansen, Katrine B.
AU - Christensen, Robin
AU - Almdal, Thomas P.
AU - Pedersen, Bente K.
AU - Karstoft, Kristian
PY - 2018
Y1 - 2018
N2 - The majority of T2D cases are preventable through a healthy lifestyle, leaving little room for questions that lifestyle should be the first line of defence in the fight against the development of T2D. However, when it comes to the clinical care of T2D, the potential efficacy of lifestyle is much less clear‐cut, both in terms of impacting the pathological metabolic biomarkers of the disease, and long‐term complications. A healthy diet, high leisure‐time physical activity, and exercise are considered to be cornerstones albeit adjunct to drug therapy in the management of T2D. The prescription and effective implementation of structured exercise and other lifestyle interventions in the treatment of T2D have not been routinely used. In this article, we critically appraise and debate our reflections as to why exercise and physical activity may not have reached the status of a viable and effective treatment in the clinical care of T2D to the same extent as pharmaceutical drugs. We argue that the reason why exercise therapy is not utilized to a satisfactory degree is multifaceted and primarily relates to a “vicious cycle” with lack of proven efficacy on T2D complications and a lack of proven effectiveness on risk factors in the primary care of T2D. Furthermore, there is a lack of experimental research establishing the optimal dose of exercise. This precludes widespread and sustained implementation of physical activity and exercise in the clinical treatment of T2D will not succeed.
AB - The majority of T2D cases are preventable through a healthy lifestyle, leaving little room for questions that lifestyle should be the first line of defence in the fight against the development of T2D. However, when it comes to the clinical care of T2D, the potential efficacy of lifestyle is much less clear‐cut, both in terms of impacting the pathological metabolic biomarkers of the disease, and long‐term complications. A healthy diet, high leisure‐time physical activity, and exercise are considered to be cornerstones albeit adjunct to drug therapy in the management of T2D. The prescription and effective implementation of structured exercise and other lifestyle interventions in the treatment of T2D have not been routinely used. In this article, we critically appraise and debate our reflections as to why exercise and physical activity may not have reached the status of a viable and effective treatment in the clinical care of T2D to the same extent as pharmaceutical drugs. We argue that the reason why exercise therapy is not utilized to a satisfactory degree is multifaceted and primarily relates to a “vicious cycle” with lack of proven efficacy on T2D complications and a lack of proven effectiveness on risk factors in the primary care of T2D. Furthermore, there is a lack of experimental research establishing the optimal dose of exercise. This precludes widespread and sustained implementation of physical activity and exercise in the clinical treatment of T2D will not succeed.
KW - clinical care
KW - complications
KW - exercise
KW - lifestyle intervention
KW - physical activity
KW - treatment
KW - type 2 diabetes
U2 - 10.1002/dmrr.2999
DO - 10.1002/dmrr.2999
M3 - Review
C2 - 29488311
VL - 34
JO - Diabetes/Metabolism Research and Reviews
JF - Diabetes/Metabolism Research and Reviews
SN - 1520-7552
IS - 5
M1 - e2999
ER -
ID: 210104299